Published 2005 | Version v1.0.0
Journal Article Open

Omega-3 Fatty Acid Supplements for Chronic Epilepsy

Abstract

Omega-3 fatty acid (FA) supplements (lg EPA and 0.7g DHA daily) were used in the treatment of 58 patients with refractory epilepsy, in a 12-week double-blind, placebo-controlled trial conducted by researchers at the UCL Institute of Neurology, London, UK.

Files

PNB-19-69.pdf

Files (1.4 MB)

Name Size Download all
md5:11ea27b57c994e499f71e9a4fbea49f8
1.4 MB Preview Download

Additional details

Identifiers

Other
PNB-19-69

Dates

Created
2005
When the item was originally created.